EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer



Reflectance confocal microscopy for characterization of mammary ductal structures and development of neoplasia in genetically engineered mouse models of breast cancer



Journal of Biomedical Optics 10(5): 051602-051602



The earliest steps of breast cancer begin with aberrations in mammary ductal structure. Techniques that enable an investigator to image in situ and then analyze the same tissue using biochemical tools facilitates identification of genetic networks and signaling pathways active in the imaged structure. Cellular confocal microscopy (VivaCell-TiBa, Rochester, New York) is used to image mammary ductal structures and surrounding vasculature in situ in intact wild-type and genetically engineered mice that develop ER alpha-initiated ductal carcinoma in situ (DCIS) and ER alpha-driven invasive mammary cancer. In wild-type mice, normal mammary ductal structures that appear from puberty through lactation are visualized and serially sectioned optically, and a developmental atlas is created. Altering tissue preparation enabled visualization of the vasculature surrounding the ductal structures. In the genetically engineered mice, aberrant mammary ductal structures and cancers are imaged and compared to corresponding normal structures. Different preparation techniques are able to preserve tissue for routine histological analyses and RNA isolation. Comparative studies demonstrate that reflectance confocal imaging provides more cellular detail than carmine-alum-stained mammary gland whole mounts and equivalent detail with hematoxylin and eosin stained tissue sections. In summary, reflectance confocal microscopy is a tool that can be used to rapidly and accurately analyze mammary gland structure.

(PDF emailed within 0-6 h: $19.90)

Accession: 012494412

Download citation: RISBibTeXText

PMID: 16292950

DOI: 10.1117/1.2065827



Related references

Genetically engineered mouse models of mammary intraepithelial neoplasia. Journal of Mammary Gland Biology and Neoplasia 5(4): 421-437, 2004

Genetically Engineered Mouse Models of Mammary Intraepithelial Neoplasia. Journal of Mammary Gland Biology and Neoplasia 5(4): 421-437, 2000

Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling. Breast Disease 28: 39-51, 2007

Time-lapse imaging of primary preneoplastic mammary epithelial cells derived from genetically engineered mouse models of breast cancer. Journal of Visualized Experiments 72): -, 2013

Overview of Genetically Engineered Mouse Models of Breast Cancer Used in Translational Biology and Drug Development. Current Protocols in Pharmacology 70: 14.36.1-14, 2016

Genetically engineered ERĪ±-positive breast cancer mouse models. Endocrine-Related Cancer 21(3): R195-R208, 2015

Genetically engineered mouse models of PI3K signaling in breast cancer. Molecular Oncology 7(2): 146-164, 2013

Studying drug resistance using genetically engineered mouse models for breast cancer. Methods in Molecular Biology 596: 33-45, 2010

Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer Subtypes. Current Protocols in Pharmacology 72: 14.38.1-11, 2016

Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models. Annals of the New York Academy of Sciences 1229: 147-155, 2011

Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models. Clinical Cancer Research 13(7): 2168-2177, 2007

Using genetically engineered mouse models of cancer to aid drug development: an industry perspective. Clinical Cancer Research 12(18): 5312-5328, 2006

Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models. Journal of Pathology 233(2): 124-137, 2014

SP-0385: The study of therapy resistance in genetically engineered mouse models for BRCA1-mutated breast cancer. RadioTherapy and Oncology 119: S180-S181, 2016

Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts. Genome Biology 14(11): R125-R125, 2015